Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Aberrant expression of MUC1 mucin in pediatric inflammatory bowel disease.

Furr AE, Ranganathan S, Finn OJ.

Pediatr Dev Pathol. 2010 Jan-Feb;13(1):24-31. doi: 10.2350/08-06-0479.1.

PMID:
19025220
2.
3.

Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.

Reddy KP, Markowitz JE, Ruchelli ED, Baldassano RN, Brown KA.

Dig Dis Sci. 2007 Feb;52(2):365-72.

PMID:
17219072
4.

Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.

Kadayakkara DK, Beatty PL, Turner MS, Janjic JM, Ahrens ET, Finn OJ.

Pancreas. 2010 May;39(4):510-5. doi: 10.1097/MPA.0b013e3181bd6501.

5.

Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease.

Hosokawa T, Kusugami K, Ina K, Ando T, Shinoda M, Imada A, Ohsuga M, Sakai T, Matsuura T, Ito K, Kaneshiro K.

J Gastroenterol Hepatol. 1999 Oct;14(10):987-96.

PMID:
10530495
6.

Immunoreactivity against Goblet cells in patients with inflammatory bowel disease.

Ardesjö B, Portela-Gomes GM, Rorsman F, Gerdin E, Lööf L, Grimelius L, Kämpe O, Ekwall O.

Inflamm Bowel Dis. 2008 May;14(5):652-61. doi: 10.1002/ibd.20370.

PMID:
18213698
7.

Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS.

Cancer Res. 1993 Feb 1;53(3):641-51.

8.

Increased expression of IL-16 in inflammatory bowel disease.

Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, Schreiber S.

Gut. 2001 Mar;48(3):326-32.

10.

Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.

Ho SB, Ewing SL, Montgomery CK, Kim YS.

Oncol Res. 1996;8(2):53-61.

PMID:
8859775
11.

Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases.

Mudter J, Weigmann B, Bartsch B, Kiesslich R, Strand D, Galle PR, Lehr HA, Schmidt J, Neurath MF.

Am J Gastroenterol. 2005 Jan;100(1):64-72.

PMID:
15654782
12.

Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.

Souza HS, Tortori CJ, Castelo-Branco MT, Carvalho AT, Margallo VS, Delgado CF, Dines I, Elia CC.

Int J Colorectal Dis. 2005 May;20(3):277-86.

PMID:
15503066
13.

Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease.

Alexander RJ, Panja A, Kaplan-Liss E, Mayer L, Raicht RF.

Dig Dis Sci. 1995 Mar;40(3):485-94.

PMID:
7895532
14.

Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.

Beatty PL, Narayanan S, Gariépy J, Ranganathan S, Finn OJ.

Cancer Prev Res (Phila). 2010 Apr;3(4):438-46. doi: 10.1158/1940-6207.CAPR-09-0194.

15.

Expression of protooncogene-encoded mRNA by colonic epithelial cells in inflammatory bowel disease.

Alexander RJ, Panja A, Kaplan-Liss E, Mayer L, Raicht RF.

Dig Dis Sci. 1996 Apr;41(4):660-9.

PMID:
8674385
16.
17.

Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.

Cao D, Wilentz RE, Abbruzzese JL, Ho L, Maitra A.

Int J Gastrointest Cancer. 2005;36(1):39-46.

PMID:
16227634
18.

O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.

Premaratne P, Welén K, Damber JE, Hansson GC, Bäckström M.

Tumour Biol. 2011 Feb;32(1):203-13. doi: 10.1007/s13277-010-0114-9.

PMID:
20872286
19.

Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.

Chinyama CN, Marshall RE, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson JD.

Histopathology. 1999 Dec;35(6):517-24.

PMID:
10583575
20.

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss.

Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, Wolf AM, Tilg H.

Gut. 2005 Apr;54(4):479-87.

Items per page

Supplemental Content

Support Center